Literature DB >> 19588364

Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well-being of women who experience intimate partner abuse.

Jean Ramsay1, Yvonne Carter, Leslie Davidson, Danielle Dunne, Sandra Eldridge, Gene Feder, Kelsey Hegarty, Carol Rivas, Angela Taft, Alison Warburton.   

Abstract

BACKGROUND: Intimate partner abuse is common in all societies and damages the health of survivors and their children in the short and long term. Advocacy may decrease the impact of this abuse on women's health.
OBJECTIVES: To assess the effects of advocacy interventions conducted within or outside of health care settings on women who have experienced intimate partner abuse. SEARCH STRATEGY: We searched: CENTRAL and DARE (Cochrane Library Issue 3, 2008), MEDLINE (1966 to 31/7/08), EMBASE (1980 to 2008 week 30), and 11 other databases, to end July 2008. We also searched relevant websites, reference lists and forward citation tracking of included studies, and handsearched six key journals. We contacted principal investigators and experts in the field. SELECTION CRITERIA: Randomised controlled trials comparing advocacy interventions for women with experience of intimate partner abuse against usual care. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and undertook data extraction. For binary outcomes we calculated a standardised estimation of the odds ratio (OR) and for continuous data we calculated either a standardised mean difference (SMD) or a weighted mean difference (WMD), both with a 95% confidence interval. MAIN
RESULTS: We included ten trials involving 1527 participants. The studies were heterogeneous in respect of: intensity of advocacy, outcome measures and duration of follow-up (immediately post-intervention to three years), permitting meta-analysis for only a minority of outcomes. Intensive advocacy (12 hours or more duration) may help terminate physical abuse in women leaving domestic violence shelters or refuges at 12-24 months follow-up (OR 0.43, 95% CI 0.23 to 0.80), but not at up to 12 months follow-up. The evidence indicates that intensive advocacy may improve quality of life at up to 12 months follow-up, but the confidence intervals included zero (WMD 0.23, 95% CI 0.00 to 0.46). Depression did not improve following intensive advocacy at up to 12 months follow-up (WMD -0.05, 95% CI -0.19 to 0.09), nor did psychological distress (SMD -0.16, 95% CI -0.39 to 0.06). Only two meta-analyses of brief advocacy interventions (less than 12 hours duration) were possible; an increased use of safety behaviours was consistent with the receipt of brief advocacy both at up to 12 months (WMD 0.60, 95% CI 0.14 to 1.06) and at 12-24 months (WMD 0.48, 95% CI 0.04 to 0.92) follow up. AUTHORS'
CONCLUSIONS: Based on the evidence reviewed, it is possible that intensive advocacy for women recruited in domestic violence shelters or refuges reduces physical abuse one to two years after the intervention but we do not know if it has a beneficial effect on their quality of life and mental health. Similarly, there is insufficient evidence to show if less intensive interventions in healthcare settings for women who still live with the perpetrators of violence are effective.

Entities:  

Mesh:

Year:  2009        PMID: 19588364     DOI: 10.1002/14651858.CD005043.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  80 in total

Review 1.  Interventions for preventing or reducing domestic violence against pregnant women.

Authors:  Shayesteh Jahanfar; Louise M Howard; Nancy Medley
Journal:  Cochrane Database Syst Rev       Date:  2014-11-12

2.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

3.  Reduction of Family Violence in Aboriginal Communities: A Systematic Review of Interventions and Approaches.

Authors:  Beverley Shea; Amy Nahwegahbow; Neil Andersson
Journal:  Pimatisiwin       Date:  2010

Review 4.  Intimate partner violence towards women.

Authors:  Laura Sadowski; Carri Casteel
Journal:  BMJ Clin Evid       Date:  2010-02-24

Review 5.  Effect of domestic violence training: systematic review of randomized controlled trials.

Authors:  Eman Zaher; Kelly Keogh; Savithiri Ratnapalan
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

6.  Women's views and experiences of antenatal enquiry for domestic abuse during pregnancy.

Authors:  Debra Salmon; Kathleen M Baird; Paul White
Journal:  Health Expect       Date:  2013-03-25       Impact factor: 3.377

7.  Primary care identification and referral to improve safety of women experiencing domestic violence (IRIS): protocol for a pragmatic cluster randomised controlled trial.

Authors:  Alison Gregory; Jean Ramsay; Roxane Agnew-Davies; Kathleen Baird; Angela Devine; Danielle Dunne; Sandra Eldridge; Annie Howell; Medina Johnson; Clare Rutterford; Debbie Sharp; Gene Feder
Journal:  BMC Public Health       Date:  2010-02-02       Impact factor: 3.295

8.  Partner violence during pregnancy: prevalence, effects, screening, and management.

Authors:  Beth A Bailey
Journal:  Int J Womens Health       Date:  2010-08-09

9.  Women's evaluation of abuse and violence care in general practice: a cluster randomised controlled trial (weave).

Authors:  Kelsey L Hegarty; Jane M Gunn; Lorna J O'Doherty; Angela Taft; Patty Chondros; Gene Feder; Jill Astbury; Stephanie Brown
Journal:  BMC Public Health       Date:  2010-01-02       Impact factor: 3.295

10.  MOSAIC (MOthers' Advocates In the Community): protocol and sample description of a cluster randomised trial of mentor mother support to reduce intimate partner violence among pregnant or recent mothers.

Authors:  Angela J Taft; Rhonda Small; Kelsey L Hegarty; Judith Lumley; Lyndsey F Watson; Lisa Gold
Journal:  BMC Public Health       Date:  2009-05-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.